Suppr超能文献

利尿剂通过增加尿中锌的排泄加重肝硬化患者的锌缺乏。

Diuretics aggravate zinc deficiency in patients with liver cirrhosis by increasing zinc excretion in urine.

机构信息

Department of Internal Medicine, Osaka Koseinenkin Hospital.

出版信息

Hepatol Res. 2013 Apr;43(4):365-73. doi: 10.1111/j.1872-034X.2012.01093.x. Epub 2012 Sep 20.

Abstract

AIM

Liver cirrhosis is often accompanied by zinc deficiency. The exact mechanisms underlying zinc deficiency remain unclear. This study was undertaken to clarify the influence of diuretics on blood zinc levels and zinc excretion in urine in liver cirrhosis.

METHODS

Seventy-nine outpatients with liver cirrhosis were divided into four groups: (i) patients receiving no zinc preparations or diuretics (LC group); (ii) those receiving zinc preparations only (LCZ group); (iii) those receiving diuretics only (LCD group); and (iv) those receiving both zinc preparations and diuretics (LCDZ group). Among these groups, the effects of the administrated drugs on blood zinc levels and urinary zinc excretion were analyzed.

RESULTS

Blood zinc levels were significantly lower in the LCD group (47.8 ± 10.5 μg/dL) than in the other groups (LC: 68.8 ± 17.1 μg/dL, P = 0.0056, post-hoc test; LCZ: 78.4 ± 18.1, P < 0.0001; LCDZ: 70.3 ± 21.4, P = 0.0008). The creatinine-adjusted urinary zinc excretion was significantly higher in the LCDZ group (548.1 ± 407.6 μg/mg creatinine) than in the other groups (LC, 58.5 ± 43.7; LCZ, 208.1 ± 227.8; LCD, 105.2 ± 154.4; each P < 0.0001). The fraction of urinary zinc excretion was also significantly higher in the LCDZ group (5.6 ± 2.9%) than in the other groups (LC, 0.6 ± 0.5; LCD, 1.7 ± 1.5; LCZ, 1.6 ± 1.2; each P < 0.0001).

CONCLUSION

In patients with liver cirrhosis, treatment with diuretics can increase zinc excretion by suppressing the reabsorption of zinc through renal tubules, which might lead to zinc deficiency.

摘要

目的

肝硬化常伴有锌缺乏。锌缺乏的确切机制尚不清楚。本研究旨在阐明利尿剂对肝硬化患者血锌水平和尿锌排泄的影响。

方法

将 79 例肝硬化门诊患者分为四组:(i)未接受锌制剂或利尿剂治疗的患者(LC 组);(ii)仅接受锌制剂治疗的患者(LCZ 组);(iii)仅接受利尿剂治疗的患者(LCD 组);以及(iv)同时接受锌制剂和利尿剂治疗的患者(LCDZ 组)。分析各组药物对血锌水平和尿锌排泄的影响。

结果

LCD 组血锌水平明显低于其他组(LC 组:68.8±17.1μg/dL,P=0.0056,组间比较;LCZ 组:78.4±18.1μg/dL,P<0.0001;LCDZ 组:70.3±21.4μg/dL,P=0.0008)。LCDZ 组尿锌排泄校正肌酐值明显高于其他组(LC 组:58.5±43.7μg/mg 肌酐;LCZ 组:208.1±227.8μg/mg 肌酐;LCD 组:105.2±154.4μg/mg 肌酐;P<0.0001)。LCDZ 组尿锌排泄分数也明显高于其他组(LC 组:0.6±0.5%;LCD 组:1.7±1.5%;LCZ 组:1.6±1.2%;P<0.0001)。

结论

在肝硬化患者中,利尿剂治疗通过抑制肾小管对锌的重吸收增加锌排泄,可能导致锌缺乏。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验